Similar articles for PMID: 34611001

Year	Number of Results
1999	1
2003	1
2005	1
2006	1
2007	4
2008	2
2009	2
2010	6
2011	7
2012	6
2013	2
2014	1
2015	3
2016	9
2017	10
2018	8
2019	6
2020	11
2021	10
2022	2

1

Impact of empirical oseltamivir discontinuation in hospitalized patients with community-acquired pneumonia after confirmed negative for influenza.

Alghanem AF, Aldhahri FA, Althemery AU. Alghanem AF, et al. Saudi Med J. 2021 Oct;42(10):1072-1077. doi: 10.15537/smj.2021.42.10.20210324. Saudi Med J. 2021. PMID: 34611001 Free PMC article.

2

Outcomes of early oseltamivir treatment for hospitalized adult patients with community-acquired influenza pneumonia.

Kositpantawong N, Surasombatpattana S, Siripaitoon P, Kanchanasuwan S, Hortiwakul T, Charernmak B, Nwabor OF, Chusri S. Kositpantawong N, et al. PLoS One. 2021 Dec 15;16(12):e0261411. doi: 10.1371/journal.pone.0261411. eCollection 2021. PLoS One. 2021. PMID: 34910777 Free PMC article.

3

Treatment with oseltamivir in children hospitalized with community-acquired, laboratory-confirmed influenza: review of five seasons and evaluation of an electronic reminder.

Wilkes JJ, Zaoutis TE, Keren R, Desai B, Leckerman KH, Hodinka RL, Metjian TA, Coffin SE. Wilkes JJ, et al. J Hosp Med. 2009 Mar;4(3):171-8. doi: 10.1002/jhm.431. J Hosp Med. 2009. PMID: 19301375

4

An international perspective on hospitalized patients with viral community-acquired pneumonia.

Radovanovic D, Sotgiu G, Jankovic M, Mahesh PA, Marcos PJ, Abdalla MI, Di Pasquale MF, Gramegna A, Terraneo S, Blasi F, Santus P, Aliberti S, Reyes LF, Restrepo MI; GLIMP Study Group. Radovanovic D, et al. Eur J Intern Med. 2019 Feb;60:54-70. doi: 10.1016/j.ejim.2018.10.020. Epub 2018 Nov 4. Eur J Intern Med. 2019. PMID: 30401576 Free PMC article.

5

Oseltamivir treatment for influenza in hospitalized children without underlying diseases.

Bueno M, Calvo C, Méndez-Echevarría A, de José MI, Santos M, Carrasco J, Tovizi M, Guillén S, de Blas A, Llorente M, Tarrago A, Escosa L, Cilleruelo MJ, Tomatis C, Blazquez D, Otheo E, Mazagatos D, García-García ML. Bueno M, et al. Pediatr Infect Dis J. 2013 Oct;32(10):1066-9. doi: 10.1097/INF.0b013e31829be4bc. Pediatr Infect Dis J. 2013. PMID: 23722530

6

Effectiveness of oseltamivir in reduction of complications and 30-day mortality in severe seasonal influenza infection.

Groeneveld GH, Marbus SD, Ismail N, de Vries JJC, Schneeberger P, Oosterheert JJ, van Dissel JT, de Boer MGJ. Groeneveld GH, et al. Int J Antimicrob Agents. 2020 Nov;56(5):106155. doi: 10.1016/j.ijantimicag.2020.106155. Epub 2020 Sep 6. Int J Antimicrob Agents. 2020. PMID: 32898685 Free article.

7

Influenza A-associated severe pneumonia in hospitalized patients: Risk factors and NAI treatments.

Zou Q, Zheng S, Wang X, Liu S, Bao J, Yu F, Wu W, Wang X, Shen B, Zhou T, Zhao Z, Wang Y, Chen R, Wang W, Ma J, Li Y, Wu X, Shen W, Xie F, Vijaykrishna D, Chen Y. Zou Q, et al. Int J Infect Dis. 2020 Mar;92:208-213. doi: 10.1016/j.ijid.2020.01.017. Epub 2020 Jan 21. Int J Infect Dis. 2020. PMID: 31978583 Free article.

8

Effectiveness of Oseltamivir in reducing 30-day readmissions and mortality among patients with severe seasonal influenza in Australian hospitalized patients.

Sharma Y, Horwood C, Hakendorf P, Thompson C. Sharma Y, et al. Int J Infect Dis. 2021 Mar;104:232-238. doi: 10.1016/j.ijid.2021.01.011. Epub 2021 Jan 9. Int J Infect Dis. 2021. PMID: 33434667 Free article.

9

Efficacy of Clarithromycin-Naproxen-Oseltamivir Combination in the Treatment of Patients Hospitalized for Influenza A(H3N2) Infection: An Open-label Randomized, Controlled, Phase IIb/III Trial.

Hung IFN, To KKW, Chan JFW, Cheng VCC, Liu KSH, Tam A, Chan TC, Zhang AJ, Li P, Wong TL, Zhang R, Cheung MKS, Leung W, Lau JYN, Fok M, Chen H, Chan KH, Yuen KY. Hung IFN, et al. Chest. 2017 May;151(5):1069-1080. doi: 10.1016/j.chest.2016.11.012. Epub 2016 Nov 22. Chest. 2017. PMID: 27884765 Clinical Trial.

10

Early Oseltamivir After Hospital Admission Is Associated With Shortened Hospitalization: A 5-Year Analysis of Oseltamivir Timing and Clinical Outcomes.

Katzen J, Kohn R, Houk JL, Ison MG. Katzen J, et al. Clin Infect Dis. 2019 Jun 18;69(1):52-58. doi: 10.1093/cid/ciy860. Clin Infect Dis. 2019. PMID: 30304487

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed